AI carries security risks in banking, including being used by scammers to target financial information. Photo via Getty Images

With artificial intelligence technologies easily accessible and growing in popularity, consumers and business owners alike should be aware of both the benefits and risks when it comes to the utilization of generative AI tools in banking and finance. While data-driven AI creates the opportunity to further drive innovation in banking, the data-reliant nature of the industry makes it a natural target for scammers looking to intercept personal and business finances and sensitive customer information.

As banks and other financial service providers are using AI as a tool to scan for anomalies or errors that are known fraud techniques, criminals are using AI to improve their chances of perpetrating fraud. For this reason, consumers and businesses should guard their data with the same diligence used to guard cash and other valuable physical property.

Privacy and accuracy

For entrepreneurs and businesses of all sizes, it is important to keep in mind the practical applications of AI beyond the trending headlines, whether implementing the technology into everyday internal business practices, or into client-facing solutions.

When feeding information into AI, it is best to maintain a defensive position and be proactive about not disclosing sensitive or private information. Also, rely on sound judgment when deciding when and how to use AI technologies. From a business standpoint, privacy should be embedded into a financial system’s design and leaders should be transparent about the technologies used within a given system.

Technologies like ChatGPT are large language models operating on massive datasets, including documents and web pages across the internet. This poses a risk because some sources of this data lack accuracy. When seeking financial advice via AI technologies, it is best to conduct research by curating and limiting the dataset then talking through your unique financial position in person with your trusted banker and IT staff or consultants.

Phishing and business email compromise via AI

Historically, phishing and business email compromise, or BEC, attempts have been more easily recognizable and often flushed out due to grammatical errors and unnecessary punctuation. With technologies like ChatGPT, scammers are now better equipped to draft well written content that can fool a person into thinking a communication is legitimate. Phishing can lead to people clicking links or attachments that harbor malware or other viruses that can lead to account takeover. With BEC, a person might be fooled into thinking an email is from a legitimate person. Scams like these could potentially lead to the disclosing of sensitive information or accepting transaction instructions or changes, ultimately resulting in money being sent to a fraudster.

AI voice generators

AI voice generators can be used to mimic voices of anyone including bankers, C-suite leaders and customers. If a person is fooled into believing they have received a voicemail or are talking to a person they know, they may accept instructions from a fraudster like providing transaction approvals and sensitive or private information, resulting in fraud.

AI can also create fake identities, including AI-developed photos of individuals, and other false information. These fake identities could be used to create accounts for fraudulent purposes.

AI is here to stay

AI is forecasted to have a lasting impact on the banking industry. Whether on the business or consumer side of the spectrum, it will be important to embrace the innovation and enhancements generative AI will continue to produce, while maintaining a cautionary stance around protecting client and business information and finances. Fraud prevention practices will need to continue evolving alongside the fast-paced growth of generative AI in banking.

------

Ken Smiley is treasury management division manager of Amegy Bank and a fraud protection expert.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston edtech company closes oversubscribed $3M seed round

fresh funding

Houston-based edtech company TrueLeap Inc. closed an oversubscribed seed round last month.

The $3.3 million round was led by Joe Swinbank Family Limited Partnership, a venture capital firm based in Houston. Gamper Ventures, another Houston firm, also participated with additional strategic partners.

TrueLeap reports that the funding will support the large-scale rollout of its "edge AI, integrated learning systems and last-mile broadband across underserved communities."

“The last mile is where most digital transformation efforts break down,” Sandip Bordoloi, CEO and president of TrueLeap, said in a news release. “TrueLeap was built to operate where bandwidth is limited, power is unreliable, and institutions need real systems—not pilots. This round allows us to scale infrastructure that actually works on the ground.”

True Leap works to address the digital divide in education through its AI-powered education, workforce systems and digital services that are designed for underserved and low-connectivity communities.

The company has created infrastructure in Africa, India and rural America. Just this week, it announced an agreement with the City of Kinshasa in the Democratic Republic of Congo to deploy a digital twin platform for its public education system that will allow provincial leaders to manage enrollment, staffing, infrastructure and performance with live data.

“What sets TrueLeap apart is their infrastructure mindset,” Joe Swinbank, General Partner at Joe Swinbank Family Limited Partnership, added in the news release. “They are building the physical and digital rails that allow entire ecosystems to function. The convergence of edge compute, connectivity, and services makes this a compelling global infrastructure opportunity.”

TrueLeap was founded by Bordoloi and Sunny Zhang and developed out of Born Global Ventures, a Houston venture studio focused on advancing immigrant-founded technology. It closed an oversubscribed pre-seed in 2024.

Texas space co. takes giant step toward lunar excavator deployment

Out of this world

Lunar exploration and development are currently hampered by the fact that the moon is largely devoid of necessary infrastructure, like spaceports. Such amenities need to be constructed remotely by autonomous vehicles, and making effective devices that can survive the harsh lunar surface long enough to complete construction projects is daunting.

Enter San Antonio-based Astroport Space Technologies. Founded in San Antonio in 2020, the company has become a major part of building plans beyond Earth, via its prototype excavator, and in early February, it completed an important field test of its new lunar excavator.

The new excavator is designed to function with California-based Astrolab's Flexible Logistics and Exploration (FLEX) rover, a highly modular vehicle that will perform a variety of functions on the surface of the moon.

In a recent demo, the Astroport prototype excavator successfully integrated with FLEX and proceeded to dig in a simulated lunar surface. The excavator collected an average of 207 lbs (94kg) of regolith (lunar surface dust) in just 3.5 minutes. It will need that speed to move the estimated 3,723 tons (3,378 tonnes) of regolith needed for a lunar spaceport.

After the successful test, both Astroport and Astrolab expressed confidence that the excavator was ready for deployment. "Leading with this successful excavator demo proves that our technology is no longer theoretical—it is operational," said Sam Ximenes, CEO of Astroport.

"This is the first of many implements in development that will turn Astrolab's FLEX rover into the 'Swiss Army Knife' of lunar construction. To meet the infrastructure needs of the emerging lunar economy, we must build the 'Port' before the 'Ship' arrives. By leveraging the FLEX platform, we are providing the Space Force, NASA, and commercial partners with a 'Shovel-Ready' construction capability to secure the lunar high ground."

"We are excited to provide the mobility backbone for Astroport's groundbreaking construction technology," said Jaret Matthews, CEO of Astrolab, in a release. "Astrolab is dedicated to establishing a viable lunar ecosystem. By combining our FLEX rover's versatility with Astroport's civil engineering expertise, we are delivering the essential capabilities required for a sustainable lunar economy."

---

This article originally appeared on CultureMap.com.

Houston biotech co. raises $11M to advance ALS drug development

drug money

Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment round.

India-based pharmaceuticals company Dr. Reddy’s Laboratories Inc. led the round with a $10 million investment, according to a news release. New York-based investment firm Greenlight Capital, Coya’s largest institutional shareholder, contributed $1.1 million.

The funding was raised through a definitive securities purchase agreement for the purchase and sale of more than 2.5 million shares of Coya's common stock in a private placement at $4.40 per share.

Coya reports that it plans to use the proceeds to scale up manufacturing of low-dose interleukin-2 (IL-2), which is a component of its COYA 302 and will support the commercial readiness of the drug. COYA 302 enhances anti-inflammatory T cell function and suppresses harmful immune activity for treatment of Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Parkinson’s disease and Alzheimer’s disease.

The company received FDA acceptance for its investigational new drug application for COYA 302 for treating ALS and FTD this summer. Its ALSTARS Phase 2 clinical trial for ALS treatment launched this fall in the U.S. and Canada and has begun enrolling and dosing patients. Coya CEO Arun Swaminathan said in a letter to investors that the company also plans to advance its clinical programs for the drug for FTD therapy in 2026.

Coya was founded in 2021. The company merged with Nicoya Health Inc. in 2020 and raised $10 million in its series A the same year. It closed its IPO in January 2023 for more than $15 million. Its therapeutics uses innovative work from Houston Methodist's Dr. Stanley H. Appel.